Research progress of mitophagy in asthma

Acta Universitatis Medicinalis Anhui     font:big middle small

Found programs: National Natural Science Foundation of China (No . 32100602) ; The High-level Talents Scien- tific Research Start-up Funds of Affiliated Hospital of Guangdong Medical University (No . GCC2021009)

Authors:He Yingzhi , Wang You , Chen Xuemei , Xie Yuwei , Ao Dang , Ke Chuanghong , Li Wen

Keywords:asthma; airway remodeling; mitophagy; Parkin-dependent mitophagy; Parkin-independent mitoph- agy; mitophagy inhibitor; mitophagy agonist

DOI:10.19405/j.cnki.issn1000-1492.2025.04.027

〔Abstract〕 Asthma is a well-characterized heterogeneous disease marked by airway remodeling and chronic air- way inflammation . Clinically , the treatment of asthma primarily relies on hormonal drugs . However , the long-term use of these medications can lead to significant side effects . Mitophagy is a biological process that selectively trans- ports damaged mitochondria to lysosomes for degradation . Recent research has revealed the crosstalk between mito- phagy and asthma. Accordingly , taking mitophagy as an entry point , summarizing the key molecular mechanisms and regulators of mitophagy in asthma will facilitate the development of novel intervention targets and strategies for asthmatic treatment.